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Abstract The heterotrimeric G protein, G~i2, transduces ignals 
from seven membrane spanning receptors to effectors such as 
adenylyl cyclase and ion channels. The purpose of this study was 
to identify these or other cellular proteins that interact with G,d2 
by use of the yeast two-hybrid system. A human B cell cDNA 
library was screened by this system using full length Gin2. Four 
positive colonies were obtained. Two of the four were identified 
as nucleobindin, a calcium binding protein and a putative antigen 
to which anti-nuclear antibodies are generated in mice with a 
disorder that resembles ystemic lupus erythematosus. Nucleo- 
bindin has a leucinc zipper, EF hands, and a signal peptide se- 
quence and is thought to localize to the nucleus as well as being 
secreted. The specificity of intehraction between G~2 and nu- 
cleobindin was confirmed by an in vitro binding assay using re- 
combinant proteins. Transfeetion of Gai2 and nucleobindin in 
COS cells increased G~i2 expression relative to cells transfected 
with Goi2 and mock vector. Our results indicate that the yeast 
two-hybrid system provides a means to identify novel proteins 
that interact with G,~ proteins. Nucleobindin appears to represent 
one of those proteins. 
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1. Introduction 
Heterotrimeric guanine nucleotide binding proteins (G pro- 
teins) transduce signals derived from receptor interaction of 
stimuli, such as peptide hormones, neurotransmitters, light and 
odorants, to various cellular effectors [1], Pertussis toxin sensi- 
tive G~ subunits of the G~ family (G~i, G~o, and G~z) have been 
shown to regulate adenylyl cyclases, K ÷ channels, and Ca 2+ 
channels [2~]. One of these proteins, G~i3, has been localized 
not only to the plasma membrane but also to the Golgi appara- 
tus, where it appears to be involved in the secretion of proteins 
[5]. G~i2, which interacts with adenylyl cyclase, causes neoplas- 
tic transformation of some types of cells when mutated to a 
constitutively active state [6]. G~i2 may also be involved in the 
regulation of cell differentiation and in transmission of signals 
from %-adrenergic receptors to the p21 ras-mitogen activated 
protein kinase pathway [7,8]. These findings suggest hat G~ 
proteins not only act as transducers of signals from the plasma 
membrane but also may play roles in unrecognized signalling 
pathways in other cellular compartments [9]. Moreover, other 
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data have suggested that G~ can be identified in the nuclei of 
cells [10]. 
We have used the yeast two-hybrid system [11] as a means 
to seek for previously unrecognized targets that could couple 
to G~i2. In this report, we identify one protein that appears to 
interact with G~i2: the human homolog of nucleobindin, a pre- 
viously cloned protein that was originally identified as a puta- 
tive auto-antigen i a model of systemic lupus erythematosus 
[121. 
2. Materials and methods 
2.1. Growth and handling of yeast strain and Escherichia coli strains 
The yeast strain used in this work was provided by S. Elledge (Baylor 
College of Medicine, Houston). The strain was Y190 (MATs gal4 
gall80 his3 trpl-190 ade2 101 ura3 52 leu2 3,-112 URA3 :: GAL-lacZ, 
LYS2:: GAL(UAS)-HIS3 cyhr). Yeast were grown in YPD (1% yeast 
extract/2% peptone/2% glucose, pH 5.8) or in the SD synthetic medium 
(0.67% yeast nitrogen basel2% glucose with appropriate auxotrophic 
amino acids). E. coli strains of XL-1 blue (Strategene) and HB101 
(Promega) were used for the purification of plasmids. Transformation 
of the yeast strain with vectors was undertaken by using modified 
instructions in the MATCHMAKER Two Hybrid System (Clontech). 
2.2, Plasmid construction and library for the yeast two-hybrid system 
In the yeast wo-hybrid system, proteins linked to the amino-terminal 
domain that mediate DNA binding join to proteins linked to the car- 
boxy-terminal domain involved in activation of GAL4 transcription 
[11]. Yeast cloning vectors containing the GAL4 DNA binding domain, 
pGBT9 and other control vectors, pVA3 containing the p53/GAL4 
DNA-binding domain, pTD1 containing SV40 large T-antigen/GAL4 
activation domain, and pLAM5' containing a human lamin C/GAL4 
DNA-binding domain were obtained from Clontech. pACT containing 
the GAL4 activation domain and pACT into which a human B cell 
cDNA library was cloned were kind gifts from S. Elledge. pGBT-Gq, 
which contains the entire coding sequence of G~q, was inserted in-frame 
to pGBT9. The entire coding sequence was amplified by PCR using the 
P3 vector (from M. Simon, Caltech) containing the entire coding se- 
quence of mouse G~q cDNA as a template, pGBT-G~2 contained in- 
frame the entire coding sequence of rat G~2 cDNA amplified from 
pG113 obtained from Y. Kaziro, DNAX. The following oligonucleo- 
tides were used for the amplification of G~q and G~2, G~q forward 
primer: 5'-CCCGGGGATCCGTATGACTCTGGAGTCCATCAT-G- 
3' including the BamHl site, G~q reverse primer: 5'- 
AAGTCGACGGATCCTTAGACCAGATTGTACTCCTTG-3' in- 
cluding the BamHl site, G~2 forward primer: 5'-TCTCGAGAATTC- 
ATGGGCTGCACCGTGAGC-3' including the EcoR1 site before the 
initiation codon, G~2 reverse: 5'-AAGCTTGTCGACTCAGAAGA- 
GGCCACAGTCCTT- 3' including the SalI site before the termination 
codon. PCR conditions were as follows: first denaturation: 3 rain at 
95°C, 30 cycles of denaturation for 30 s at 95°C, annealing for 30 s at 
55°C and extension for 30 s at 72°C. PCR products of G~q and G~,2 
were digested with appropriate r striction enzymes, purified from aga- 
rose gel and ligated into pGBT9. 
pGST G~2 contain the entire coding sequence of G~2 expressed as a 
fusion protein to GST. The coding sequence was amplified by the set 
of forward and reverse primers; 5'-GGTGGAATTCTAATGGGCTG- 
CACCGTGAGCGCC-3' and 5'-AAGCTTGTCGACTCAGAAGA- 
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GGCCACAGTCCTT-Y. The amplified products were digested with 
EcoRI and Sail, and ligated in-frame into pGEX-KG, which is a deriv- 
ative of pGEX-2T (Pharmacia). pBluescript (pBS)-Nuc contained 
human nucleobindin cDNA. pcDNA-Gi: was made by ligation of 
pcDNA3 (Invitrogen) digested with EcoRl and the EcoRI fragment 
from pGI 13 that contained rat G~2 cDNA, including the 5' non-coding 
region and the entire coding sequence digested with EcoRl. pcDNA- 
Nuc was constructed with the ligation of pcDNA digested with EcoRI 
and the EcoRI fragment from pBS-Nuc. All of the plasmids used in this 
experiment were sequenced inboth directions by the Sequenase v rsion 
2.0 kit (U.S. Biochemical Corp) and/or analyzed by combinations of 
restriction enzyme digestion. 
2.3. Library screening with the yeast two-hybrid system 
Y190 was transformed with pGBT-G~2 using the lithium acetate pro- 
cedure and grown on the SD plate in the absence of Trp. Colonies that 
appeared on the plate did not have transcription activation activity by 
themselves. Transformants with pGBT-G~2 were grown in the SD me- 
dium and sequentially transformed by 200/~g of the human B cell 
library inserted into pACT. Transformants were incubated on SD 
plates with 50 mM of 3-aminotriazole in the absence of Ura, Leu, Trp 
and His. Clones that could grow in the absence of His and that could 
activate the lacZ reporter gene were isolated. Plasmids containing an 
activation domain and protein that interacted with G~ in the yeast 
were purified from lacZ positive colonies. HB101 transformed with 
plasmids purified from yeast hat could grow in the absence of Leu on 
the M9 plates possessed the activation domain plasmids. 
2.4. Qualitative and quantitative fl-galactosidase assays 
A filter assay for qualitative analysis offl-galactosidase and liquid 
culture assay for fl-galactosidase w re performed according to the in- 
structions of the MATCHMAKER Two-Hybrid System. Data for 
quantitative assays are mean _+ S.D. of triplicate assays representing 
Miller's units. 
2.5. In vitro binding studies using GST fusion proteins 
XL-1 blue transformed pGEX-KG or pGEX-Gi2 were grown in the 
5 ml of LB broth in the presence of ampicillin overnight, diluted to 250 
ml and incubated with IPTG for 7 h. Bacterial pellets were suspended 
in 5 ml of phosphate buffered saline (PBS) containing protease inhib- 
itors (pepstatin 5/lg/ml, leupeptin 10/tg/ml, benzamadine hydrochlo- 
ride 2 mM, phenylmethylsulfonyl fluoride 5 mM, EDTA 3 mM, and 
aprotinin 50 KIU/ml). Cells were sonicated four times each for 30 s 
followed by addition of 0.5 ml of 10% Nonidet P(NP)-40. The lysates 
were centrifuged for 10 min at 5,000 x g at 4°C. Pellets were suspended 
with 5 ml of 1.5% N-lauroylsarcosine, 25mM triethanolamine, lmM 
EDTA, pH 8.0, mixed for 10 min at 4°C and recentrifuged at 10,000 x g 
for 10 min at 4°C. NP-40 and CaC12 were added to the second superna- 
tant to final concentrations of 2% and 1 mM, respectively. The first and 
second supernatants were combined, suspended in 50 ml PBS with 
protease inhibitors, added to 400 ~1 of glutathione agarose, and rotated 
at 4°C for 1 h. The agarose was washed five times with PBS containing 
0.1% NP-40. GST-Gi2 was electrophoresed on a 10% SDS-poly- 
acrylamide gel (PAGE), transferred to Immobilon (Millipore) and de- 
tected by using anti-G~2 antibody (AS7, DuPont-NEN). The blot was 
visualized by ECL (Amersham). 
Nucleobindin was produced and labeled with [35S]Met by an in vitro 
transcription/translation system TNT kit (Promega) under the control 
of the T7 and T3 promoters, respectively, using pBS-Nuc. GST-Gi2 
agarose containing 5/,tg of GST-Giz or GST agarose was incubated with 
1 mM GDP or GTP~,S in 50 mM Tris containing 50 mM NaC1, 5 mM 
EDTA without Mg 2+ for 30 min at 30°C, followed by addition of 5 mM 
MgC12 at 4°C and washed by binding buffer (20 mM Tris pH 7.5, 150 
mM NaCI, 3 mM EDTA, 0.1% NP-40) with 1 mM DTT and the 
previously mentioned protease inhibitors. Subsequently, GST-G~2 aga- 
rose was incubated with the in vitro translated products at 4°C for 12 
h, washed 5 times with binding buffer and centrifuged. The pellet was 
eluted with SDS-PAGE sample buffer and subjected to 10% SDS- 
PAGE. 
2.6. Coexpression of G=a and nucleobindin i  COS cells 
COS-1 cells were transfected with pcDNA/pcDNA-G~2 or pcDNA/ 
pcDNA-Nuc or pcDNA-GiJpcDNA-Nuc, by the use of Lipofectamine 
(GIBCO). After 48 h, cells were solubilized in 20 mM Tris, 150 mM 
pGBT9 
pVA3 
pLAM5' 
pGBT9-Gi2 
pGBT9-Gq 
pVA3 
pACT-Nuc 
pTD1 
Fig. 1. Filter assay for fl-galactosidase. Y190 was transformed with 
both vectors listed in the column and row. The result from yeast rans- 
formed with pVA3 and pTDI used as a control is on the bottom line. 
The combinations of pGBT-GJpACT-Nuc and the control combina- 
tion of pVA3 and pTD1 showed positive reactions, fl-Galactosidase 
activity measured in Miller's units (mean + S.D.) with pACT-Nuc were 
as follows: pGBT9, 0.21_+0.06; pVA3, 0.13 +0.05; pLAM 5', 
0.11 + 0.05; pGBT9-G~2, 9.73 _+ 3.88; pGBT9-Gq, 0.15 _+ 0.08. Activity 
with pVA3 plus pTD1 was 136.4 + 15.83. All values for pACT alone 
and together with other constructs were 0.10~. 13. 
NaC1, 3 mM EDTA and 0.1% NP-40 with protease inhibitors, followed 
by 1 h incubation at 4°C. After centrifugation for 30 min at 5,000 × g, 
the supernatant was subjected to 10% SDS-PAGE and transferred to 
Immobilon. Immunodetection was performed using the AS-7 antibody. 
3. Results 
Screening of a human B cell cDNA library by the yeast 
two-hybrid system showed that four of 1.4 x 106 double trans- 
formants displayed lacZ and were His positive. The library 
cDNAs from 4 doubly positive colonies were purified and se- 
quenced. Two of the four transformants had the GAL4 activa- 
tion domain followed by nucleotides that encoded a partial 
fragment of nucleobindin, a 461 amino acid protein isolated as 
a nuclear antigen in a murine model of systemic lupus erythe- 
matosus [12]. The sequence downstream of the GAL4 activa- 
tion domain started from aa47 Gly in one and aa139 His in the 
other transformant encoding nucleobindin. We tested various 
combinations of control vectors and pGBT9-Gq. A filter assay 
for fl-galactosidase activity showed that yeast ransformed with 
the combination of pGBT9-Gi2 and pACT-Nuc had the ability 
to induce the lacZ, but this was not the case for the combination 
of pGBT9-Gq and pACT-Nuc (Fig. 1). The GAL4 binding 
domain was unable to interact with either nucleobindin, p53 in 
pVA3 and lamin in pLAM5'  also could not interact with nu- 
cleobindin, nor did pACT-G~2 itself activate the reporter gene. 
The above results, observed with both filter assays and liquid 
culture assays (Fig. 1 legend), confirmed that interactions be- 
tween G~i 2 and nucleobindin are specific in this two-hybrid 
system. 
In order to test the specificity of coupling of nucleobindin 
and G~i 2 identified in the yeast two-hybrid system, we per- 
formed in vitro binding assays using a GST-Gi2 fusion protein 
and nucleobindin produced by rabbit reticulocyte lysates. The 
GST-G~2 fusion protein, but not GST alone, bound [35S]Met- 
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labelled nucleobindin. Neither GDP nor GTP~'S changed the 
ability of G~i2 to bind nucleobindin (Fig. 2). 
In order to examine possible interaction of the proteins 
during their expression, we transfected COS cells with the 
combination of pcDNA3/pcDNA-Gi2, pcDNA/pcDNA-Nuc, 
pcDNA-GJpcDNA-Nuc,  or mock/pcDNA-3. Solubilized 
fractions of transformants were subjected to the SDS-PAGE 
followed by immunodetection using anti-G~i2 antibody. The 
G~i2 protein expression level of the transformant produced by 
the combination of Gai 2 and Nuc was greater than that pro- 
duced by G~ 2 and mock vector (Fig. 3). 
4. Discussion 
Although heterotrimeric G proteins couple to seven mem- 
brane-spanning receptors and their effectors, evidence has been 
presented regarding linkage of such G proteins to other types 
of molecules. For example, a G protein can couple to the 
insulin-like growth factor-II/mannose 6-phosphate receptor 
[13], G~o can be associated with a nerve growth cone protein, 
GAP-43 [14,15], and a pertussis toxin-sensitive G protein has 
been implicated in neural growth via interaction with a neural 
cell adhesion molecule and N-cadherin [16]. G=i has also been 
detected in organelles other than the plasma membrane (e.g. 
[9,17,18]). 
The yeast two-hybrid system allowed us to demonstrate in- 
teraction between G~i2 and the protein nucleobindin. This inter- 
action was also observed in an in vitro binding assay and 
transfection with nucleobindin i  COS cells increased G~i 2 ex- 
pression. The binding activity of G=i 2 and nucleobindin did not 
appear to depend on guanine nucleotide, as is also noted for 
receptor interaction with G~ proteins [19]. 
Nucleobindin was originally cloned as a nuclear antigen in 
a murine model of systemic lupus erythematosus [12,20]. Inter- 
estingly, it has a DNA-binding motif, leucine zipper, a signal 
peptide sequence, and an EF hand motif for Ca 2÷ binding 
activity [12,20~2]. Nucleobindin was independently cloned by 
investigators studying mineralized matrix of bovine bone and 
was detected in osteoid and around osteocytes ofcompact bone 
[22]. Among several tissues, the highest levels of protein were 
found in bone. It is intriguing that the action of several types 
fusion protein GST / GST-GI2 
nucleotids (-) GDP GTPyS (-) GDP GTP-IS 
142- 
97- 
50- 
kDa 35- 
Nuc 
Fig. 2. In vitro binding assay of GST, GST-G~2 and in vitro translated 
nucleobindin. GST or GST-Gi2 were incubated with [35S]Met labelled 
nucleobindin in the presence or absence of GDP or GTPyS. After 
several washings, the precipitate was subjected to 10% SDS-PAGE, 
followed by drying and exposure to X-ray film. Nuc, nucleobindin. 
4- 
Z 
+ 
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Fig. 3. G~i 2 expression of transfected COS cells. Equal amounts of 
solubilized extract from transfectants expressing G~i2 obtained by trans- 
fection of pcDNA-G~2 alone or together with pcDNA-Nuc were sub- 
jected to 10% SDS-PAGE and immunoblotted with AS7. Numbers on 
the left indicate molecular weight (kDa). 
of hormones that can influence bone formation or resorption 
are sensitive in inhibition by pertussis toxin (e.g. [23 26]). 
The ability of coexpressed nucleobindin to enhance Gc~i2 ex- 
pression suggests functional interaction between G~i2 and nu- 
cleobindin so as to influence transcription/translation of G~i 2. 
Alternatively, the combination of these two-proteins may pro- 
tect G~i2 from protease degradation. Whether Gcti2 can influence 
nucleobindin expression will require further study. 
Previous data suggest hat G proteins can exist in the cell 
nucleus. G proteins that can be detected by anti-G~i antibody 
exist in the nucleus of rat liver [t0] and MDCK cells (M. Balboa 
and P.A. Insel, unpublished observations). Gas has been de- 
tected in the nucleus of $49 lymphoma cells [25]. Such results 
suggest that G~i2 and nucleobindin may interact in the nucleus. 
Other data have demonstrated that heterotrimeric G proteins 
exist on the trans-Golgi network and can affect secretory vesicle 
formation [9]. Since nucleobindin has a signal peptide sequence 
and is secreted from murine cells, perhaps G~2 is involved in 
the secretion of this molecule. 
In summary, the current data show that use of the yeast 
two-hybrid system yields evidence of interaction of G=~ 2 and 
nucleobindin, a previously identified calcium binding protein 
and putative auto-antigen i an animal model of lupus erythe- 
matosus. It is intriguing to speculate that interaction of nu- 
cleobindin and G~2 may have physiologic importance for bone 
and perhaps other tissues. 
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